Cardio Diagnostics Holdings Inc. develops clinical solutions for the early detection and management of cardiovascular diseases, particularly coronary heart disease (CHD). The company utilizes epigenetic and genetic biomarkers to provide personalized risk assessments and insights, aiming to improve patient outcomes and reduce healthcare costs. Its offerings include risk assessment tools, coronary heart disease detection services, and a population health platform for real-time cardiovascular risk profiling. Cardio Diagnostics serves healthcare providers, patients, and employers across the United States.
